Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898044531> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2898044531 endingPage "141" @default.
- W2898044531 startingPage "141" @default.
- W2898044531 abstract "Background Because of the durability, non-resorbable GBR membrane is believed to achieve the good outcome. But it need second-stage removal and have higher exposure rate. Resorbable animal collagen membrane is widely used as good operationality. But they remain have the risk of unknown pathogen. So we developed synthetic GBR membrane GMEM-B2 adopting resorbable copolymer P(LA CL). It can offer longer resorption period and also have soft and flexible feature to follow and fit to the outline of bone tissue. Aim/Hypothesis It is also known that stiff resorbable membranes promotes a similar degree of bone formation as non-resorbable membranes. In this study we checked the longer duration and biological safety of the prototype in in vitro degradation test and in subchronic toxicity test. Material and Methods GMEM-B2 is consisted of copolymer of e-caprolactone and L-lactide (P(LA CL)), which undergo hydrolysis in body fluids. It have bilayer (porous and solid) structure. Former is to face to bone for good integration, and latter is to block soft tissue invasion. In vitro degradation test was performed in accordance with the ISO158114-1999. In short, 13 mm-dia. round specimen was soaked in PBS (pH 7.4), at 37°C (n = 4). Every 4 or 8w, they were rinsed and dried to check the mass loss. 50% mass loss period of GMEM-B2 was compared with GC Membrane (GC Corp.,) Subchronic toxicity test of GMEM-B2 was performed according to the ISO10993-6-2016 and ISO10993-11-2006. Briefly, both sexual of BrlHan-WIST rats were used (n = 6). Samples were implanted for calvaria onlay and subcutaneous (Exposure margin-113). Also sham op. was performed as control. At 18w, as main test item, hematological and blood biochemistry data was determined, and test sites were examined macroscopically and histologically. Results From in vitro degradation test, it is turned that mass of each group were decreased in a linear fashion from 8 w. Period of 50% mass loss was 28.8w for GMEM-B2 and 13.4w for GC Membrane. Then we determined 18w as the time point of the subchronic toxicity test (as the middle of active degradation phase) for GMEM-B2. Subchronic toxicity test, no animals showed sample-related toxic symptoms. There were only toxicologically negligible differences in hematological results. Macroscopic and histological test revealed no significant abnormalities and inflammation in all groups. In histologicals, the tissue reactions against the test strips were mainly foreign body reactions. Many giant cells were present on the porous layer side, and cellular infiltration, mainly macrophages, into the test strips was noted. But it is also suggested that substantial barrier properties of GMEM-B2 were not compromised at 18w. In the subcutaneous implantation sites, similar tissue reactions were observed. Conclusions and Clinical Implications It was found that the 50% degradation time of GMEM-B2 was twice as GC Membrane (degrades in 12–16w in vivo). And GMEM-B2 did not cause subchronic systemic toxicity and inflammatory reactions. Because in literatures, it is said that some commercially succeeded collagen GBR membrane degrades in 12w or less in vivo. Taken together these results, GMEM-B2 is presumed to have enough potential in clinical application." @default.
- W2898044531 created "2018-10-26" @default.
- W2898044531 creator A5009958813 @default.
- W2898044531 creator A5011296110 @default.
- W2898044531 creator A5030285650 @default.
- W2898044531 creator A5044407801 @default.
- W2898044531 creator A5050736907 @default.
- W2898044531 creator A5057271074 @default.
- W2898044531 creator A5079951086 @default.
- W2898044531 creator A5085441387 @default.
- W2898044531 date "2018-10-01" @default.
- W2898044531 modified "2023-09-26" @default.
- W2898044531 title "Evaluation of new synthetic resorbable membrane for GBR- Degradation and Subchronic toxicity test" @default.
- W2898044531 doi "https://doi.org/10.1111/clr.26_13358" @default.
- W2898044531 hasPublicationYear "2018" @default.
- W2898044531 type Work @default.
- W2898044531 sameAs 2898044531 @default.
- W2898044531 citedByCount "0" @default.
- W2898044531 crossrefType "journal-article" @default.
- W2898044531 hasAuthorship W2898044531A5009958813 @default.
- W2898044531 hasAuthorship W2898044531A5011296110 @default.
- W2898044531 hasAuthorship W2898044531A5030285650 @default.
- W2898044531 hasAuthorship W2898044531A5044407801 @default.
- W2898044531 hasAuthorship W2898044531A5050736907 @default.
- W2898044531 hasAuthorship W2898044531A5057271074 @default.
- W2898044531 hasAuthorship W2898044531A5079951086 @default.
- W2898044531 hasAuthorship W2898044531A5085441387 @default.
- W2898044531 hasBestOaLocation W28980445311 @default.
- W2898044531 hasConcept C136229726 @default.
- W2898044531 hasConcept C15920480 @default.
- W2898044531 hasConcept C178790620 @default.
- W2898044531 hasConcept C185592680 @default.
- W2898044531 hasConcept C29730261 @default.
- W2898044531 hasConcept C3019778037 @default.
- W2898044531 hasConcept C41625074 @default.
- W2898044531 hasConcept C43617362 @default.
- W2898044531 hasConcept C50670333 @default.
- W2898044531 hasConcept C521977710 @default.
- W2898044531 hasConcept C55493867 @default.
- W2898044531 hasConcept C71924100 @default.
- W2898044531 hasConcept C94412978 @default.
- W2898044531 hasConceptScore W2898044531C136229726 @default.
- W2898044531 hasConceptScore W2898044531C15920480 @default.
- W2898044531 hasConceptScore W2898044531C178790620 @default.
- W2898044531 hasConceptScore W2898044531C185592680 @default.
- W2898044531 hasConceptScore W2898044531C29730261 @default.
- W2898044531 hasConceptScore W2898044531C3019778037 @default.
- W2898044531 hasConceptScore W2898044531C41625074 @default.
- W2898044531 hasConceptScore W2898044531C43617362 @default.
- W2898044531 hasConceptScore W2898044531C50670333 @default.
- W2898044531 hasConceptScore W2898044531C521977710 @default.
- W2898044531 hasConceptScore W2898044531C55493867 @default.
- W2898044531 hasConceptScore W2898044531C71924100 @default.
- W2898044531 hasConceptScore W2898044531C94412978 @default.
- W2898044531 hasLocation W28980445311 @default.
- W2898044531 hasLocation W28980445312 @default.
- W2898044531 hasOpenAccess W2898044531 @default.
- W2898044531 hasPrimaryLocation W28980445311 @default.
- W2898044531 hasRelatedWork W2016792520 @default.
- W2898044531 hasRelatedWork W2024349192 @default.
- W2898044531 hasRelatedWork W2060456622 @default.
- W2898044531 hasRelatedWork W2090168574 @default.
- W2898044531 hasRelatedWork W2095581038 @default.
- W2898044531 hasRelatedWork W2326430580 @default.
- W2898044531 hasRelatedWork W2403182174 @default.
- W2898044531 hasRelatedWork W2442653137 @default.
- W2898044531 hasRelatedWork W2950717927 @default.
- W2898044531 hasRelatedWork W4301304806 @default.
- W2898044531 hasVolume "29" @default.
- W2898044531 isParatext "false" @default.
- W2898044531 isRetracted "false" @default.
- W2898044531 magId "2898044531" @default.
- W2898044531 workType "article" @default.